Thomas A. Stamey

Stanford Medicine — United States

Medicine · Health Sciences

89h-index29.3kcitations361works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(178), Prostate Cancer Treatment and Research(149), Urologic and reproductive health conditions(88), Urinary Bladder and Prostate Research(45), Urinary Tract Infections Management(44)

Publications361 total

PROSTATE BIOPSY OUTCOME PREDICTION – COMPARISON OF A NOVEL LOGISTIC REGRESSION-BASED MODEL, THE PROSTATE CANCER RISK CALCULATOR AND PSA ALONE
The Journal of Urology·2008
What Every Patient Should Know about Prostate Cancer Before He Submits to Biopsy of His Prostate
Humana Press eBooks·2008
Discovery and Validation of 3 Novel DNA Methylation Markers of Prostate Cancer Prognosis
The Journal of Urology·2007· 96 cited
1874: External Validation of the Prostate Cancer Risk Calculator
The Journal of Urology·2007· 3 cited
860: Protein C Inhibitor as a Biomarker for Prostate Cancer: Detection, Staging, and Prediction of Recurrence
The Journal of Urology·2006
RE: THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?
The Journal of Urology·2005· 3 cited
Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer
Cancer Letters·2005· 18 cited
The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA
British Journal of Urology·2004· 36 cited
THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?
The Journal of Urology·2004· 547 cited
Frequent HIN-1 Promoter Methylation and Lack of Expression in Multiple Human Tumor Types
Molecular Cancer Research·2004· 55 citedOpen Access
626: Serum PSA After 1998 is Unrelated to Prostate Cancer: What Happened in the Past 20 Years?
The Journal of Urology·2004Open Access
Elevated Expression of Inhibin α in Prostate Cancer
The Journal of Urology·2004· 21 cited
Oncology: Prostate/Testis/Penis/Urethra THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?
2004· 2 cited
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer
Urology·2003· 14 cited
Genetic Profiling of Gleason Grade 4/5 Prostate Cancer: Which is the Best Prostatic Control Tissue?
The Journal of Urology·2003· 18 cited
Complexed Prostate Specific Antigen Improves Specificity for Prostate Cancer Detection: Results of a Prospective Multicenter Clinical Trial
The Journal of Urology·2003· 125 cited
Editorial: More Information on Prostate Specific Antigen and Prostate Cancer
The Journal of Urology·2003· 14 cited
Prognostic Factors for Multifocal Prostate Cancer in Radical Prostatectomy Specimens: Lack of Significance of Secondary Cancers
The Journal of Urology·2003· 214 cited
Hepsin and Maspin are Inversely Expressed in Laser Capture Microdissectioned Prostate Cancer
The Journal of Urology·2003· 83 cited
Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
PubMed·2003· 67 cited
page 1 of 19Next →

Frequent Co-authors

John E. McNeal(23), Fuad S. Freiha(15), Elise A. Redwine(8), John N. Kabalin(5), Arnauld Villers(5), Norman Yang(3), Kathryn K. Hodge(3), Martha K. Terris(3), Iain M. Johnstone(3), Edwin M. Meares(3), Rosalie Nolley(3), CHERYL M. YEMOTO(3), Michelle Ferrari(3), Hans‐Peter Schmid(2), MITCHELL C. CALDWELL(2), Masanori Noguchi(2), Howard M. Price(2), Jackson E. Fowler(2), Donald G. Winningham(2), E. Stewart Geary(2)